Caseware UK (AP4) 2023.0.135 2023.0.135 2024-04-302024-04-303true2023-05-01falseNo description of principal activity4trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 09180742 2023-05-01 2024-04-30 09180742 2022-05-01 2023-04-30 09180742 2024-04-30 09180742 2023-04-30 09180742 c:Director1 2023-05-01 2024-04-30 09180742 d:PlantMachinery 2023-05-01 2024-04-30 09180742 d:PlantMachinery 2024-04-30 09180742 d:PlantMachinery 2023-04-30 09180742 d:PlantMachinery d:OwnedOrFreeholdAssets 2023-05-01 2024-04-30 09180742 d:FurnitureFittings 2023-05-01 2024-04-30 09180742 d:FurnitureFittings 2024-04-30 09180742 d:FurnitureFittings 2023-04-30 09180742 d:FurnitureFittings d:OwnedOrFreeholdAssets 2023-05-01 2024-04-30 09180742 d:OfficeEquipment 2023-05-01 2024-04-30 09180742 d:OfficeEquipment 2024-04-30 09180742 d:OfficeEquipment 2023-04-30 09180742 d:OfficeEquipment d:OwnedOrFreeholdAssets 2023-05-01 2024-04-30 09180742 d:OwnedOrFreeholdAssets 2023-05-01 2024-04-30 09180742 d:CurrentFinancialInstruments 2024-04-30 09180742 d:CurrentFinancialInstruments 2023-04-30 09180742 d:CurrentFinancialInstruments d:WithinOneYear 2024-04-30 09180742 d:CurrentFinancialInstruments d:WithinOneYear 2023-04-30 09180742 d:ShareCapital 2024-04-30 09180742 d:ShareCapital 2023-04-30 09180742 d:RetainedEarningsAccumulatedLosses 2024-04-30 09180742 d:RetainedEarningsAccumulatedLosses 2023-04-30 09180742 c:FRS102 2023-05-01 2024-04-30 09180742 c:AuditExempt-NoAccountantsReport 2023-05-01 2024-04-30 09180742 c:FullAccounts 2023-05-01 2024-04-30 09180742 c:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 09180742 e:PoundSterling 2023-05-01 2024-04-30 iso4217:GBP xbrli:pure
Registered number: 09180742









APPLIED GENOMICS LTD

UNAUDITED

FINANCIAL STATEMENTS
INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 APRIL 2024

 
APPLIED GENOMICS LTD
REGISTERED NUMBER: 09180742

BALANCE SHEET
AS AT 30 APRIL 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 4 
31,622
17,345

Current assets
  

Stocks
  
7,278
12,950

Debtors: amounts falling due within one year
 5 
58,787
71,376

Cash at bank and in hand
  
37,289
98,507

  
103,354
182,833

Creditors: amounts falling due within one year
 6 
(483,286)
(476,162)

Net current liabilities
  
 
 
(379,932)
 
 
(293,329)

  

Net liabilities
  
(348,310)
(275,984)


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
(348,410)
(276,084)

  
(348,310)
(275,984)


The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 31 January 2025.




................................................
I M Wilson
Director

Page 1

 
APPLIED GENOMICS LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

1.


General information

Applied Genomics Ltd is a private company limited by shares and incorporated in England and Wales, with the registration number 09180742. The registered office is Unit A Greengates Way, Hoveton, Norfolk, United Kingdom, NR12 8ED.
 
The financial statements are rounded to the nearest £.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Going concern

The director considers that the resources available to the company will be sufficient for it to be able to continue as a going concern. The financial statements do not contain any adjustments that would be required if the company were not able to continue as a going concern. 
The company relies on the financial support of its controlling party Asteroceras Group Ltd. 
The financial statements do not contain any adjustments that would be required if the company were not able to continue as a going concern.

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

Page 2

 
APPLIED GENOMICS LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

2.Accounting policies (continued)

 
2.4

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Plant and machinery
-
15%
straight line
Fixtures and fittings
-
15%
straight line
Office equipment
-
25%
straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.6

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.7

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Page 3

 
APPLIED GENOMICS LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

2.Accounting policies (continued)

 
2.8

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees



The average monthly number of employees, including directors, during the year was 4 (2023 - 3).


4.


Tangible fixed assets





Plant and machinery
Fixtures and fittings
Office equipment
Total

£
£
£
£



Cost or valuation


At 1 May 2023
87,464
-
10,376
97,840


Additions
-
18,009
1,602
19,611



At 30 April 2024

87,464
18,009
11,978
117,451



Depreciation


At 1 May 2023
75,067
-
5,427
80,494


Charge for the year on owned assets
2,380
1,458
1,497
5,335



At 30 April 2024

77,447
1,458
6,924
85,829



Net book value



At 30 April 2024
10,017
16,551
5,054
31,622



At 30 April 2023
12,396
-
4,949
17,345

Page 4

 
APPLIED GENOMICS LTD
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024

5.


Debtors

2024
2023
£
£


Trade debtors
37,900
59,752

Other debtors
12,884
10,522

Prepayments and accrued income
8,003
1,102

58,787
71,376



6.


Creditors: Amounts falling due within one year

2024
2023
£
£

Trade creditors
6,988
27,350

Amounts owed to group undertakings
452,512
427,384

Other taxation and social security
18,030
16,236

Other creditors
809
2,344

Accruals and deferred income
4,947
2,848

483,286
476,162



7.


Pension commitments

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company  in an independently administered fund. The pension cost charge represents contributions payable by the Company  to the fund and amounted to £3,901 (2023 - £2,635). Contributions totalling £809 (2023 - £694) were payable to the fund at the balance sheet date and are included in creditors.


8.


Controlling party

The controlling party is Asteroceras Group Ltd.


Page 5